NOVAREX Co.,Ltd. (KOSDAQ:194700)
South Korea · Delayed Price · Currency is KRW 14,340
-400 (-2.71%)
At close: Feb 6, 2026
NOVAREX Market Cap
NOVAREX has a market cap or net worth of 253.85 billion as of February 6, 2026. Its market cap has increased by 86.23% in one year.
Market Cap
253.85B
Enterprise Value
266.30B
Revenue
385.76B
Ranking
n/a
PE Ratio
7.03
Stock Price
14,340.00
Market Cap Chart
Since November 14, 2018, NOVAREX's market cap has increased from 180.98B to 253.85B, an increase of 40.27%. That is a compound annual growth rate of 4.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 253.85B | 2.43% |
| Dec 30, 2025 | 247.83B | 86.67% |
| Dec 30, 2024 | 132.77B | -38.22% |
| Dec 28, 2023 | 214.90B | 19.61% |
| Dec 29, 2022 | 179.68B | -41.23% |
| Dec 30, 2021 | 305.72B | -1.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellBion | 327.20B |
| DAE HWA Pharmaceutical | 264.85B |
| Vivozon Pharmaceutical | 221.49B |
| Organoidsciences | 206.12B |
| GREEN CROSS WellBeing | 170.18B |
| BL Pharmtech | 161.67B |
| Kyung Dong Pharmaceutical | 149.80B |
| PHARMARESEARCH BIO | 145.49B |